To conclude, our results suggest that HNPMI acts as an effective EGFR inhibitor and exhibits potential anti‐cytotoxicity and anti‐proliferative activity in CRC cells by inducing the intrinsic apoptotic pathway and oncogenesis pathway. Here, EGFR is linked to colorectal carcinoma.